#Pharmacy #PharmD #ClinicalPharmacy #Diabetes #SGLT2Inhibitors #PatientSafety #HealthcareInnovation To view or add a comment, sign in The FDA has approved Lipfendra (enlicitide) the first oral inhibitor of PCSK9 as an adjunct to diet and exercise to reduce LDL, or bad, cholesterol in adults with high cholesterol, including those with heterozygous familial hypercholesterolemia (HeFH)
Amylin: pharmacology, physiology, and clinical potential
Personal or family thyroid cancer history, MEN2 history, diabetes medications, and cancer history are important clinician discussion points
The gut is being asked to move food more slowly than normal, and rich fatty meals compound that effect
Researchers who prefer a pre-measured click-dose format instead of manual reconstitution can compare this vial with our Retatrutide Pen 30mg, which contains the same total content and purity